Real-time enrollment status for this transthyretin amyloidosis with cardiomyopathy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:41 AM UTC
| NCT Number | NCT07358078 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloidosis With Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 2,000 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Alnylam Pharmaceuticals |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of July 13, 2026: Clinical trial NCT07358078 is currently recruiting participants. This clinical trial study for transthyretin amyloidosis with cardiomyopathy is actively seeking new participants at 4 locations across the United States. The study is sponsored by Alnylam Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07358078 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07358078 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.